Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Morgan Black

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Clinical Lung Cancer|December 15, 2023
Detection of Circulating Tumor DNA After Stereotactic Ablative Radiotherapy in Patients With Unbiopsied Lung Tumors (SABR-DETECT)Saurav Verma, Sympascho Young, Thomas A C Kennedy, et al.
Journal of Robotic Surgery|August 8, 2024
Outcomes of open versus robotic partial nephrectomy: a 20-year single institution experienceHarrison Love, Courtney Yong, James E Slaven, et al.
Pathology Oncology Research : POR|August 15, 2015
Feasibility of Targeting PIK3CA Mutations in Head and Neck Squamous Cell CarcinomaJulie A Theurer, William Stecho, John Yoo, et al.
Oncotarget|June 15, 2018
High-throughput testing in head and neck squamous cell carcinoma identifies agents with preferential activity in human papillomavirus-positive or negative cell linesFarhad Ghasemi, Morgan Black, Ren X Sun, et al.
Oncotarget|October 27, 2017
Repurposing Albendazole: new potential as a chemotherapeutic agent with preferential activity against HPV-negative head and neck squamous cell cancerFarhad Ghasemi, Morgan Black, Frederick Vizeacoumar, et al.
Oral Oncology|December 23, 2019
Spleen tyrosine kinase expression is correlated with human papillomavirus in head and neck cancerMorgan Black, Farhad Ghasemi, Ren X Sun, et al.
The Journal of Molecular Diagnostics : JMD|February 7, 2026
Health care impact of comprehensive genomic profiling of solid tumors in patient management using POWER (Precision Oncology at Western University)Pratibha Bhai, Jacob P Turowec, Lee-Anne Pickard, et al.
Lung Cancer (Amsterdam, Netherlands)|July 29, 2024
Treatment patterns and outcomes in KRAS<sup>G12C</sup>-positive advanced NSCLC patients previously treated with immune checkpoint inhibitors: A Canada-wide real-world, multi-center, retrospective cohort studySamir H Barghout, Luna Jia Zhan, Starvroula Raptis, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Clinical Lung Cancer|December 15, 2023
Detection of Circulating Tumor DNA After Stereotactic Ablative Radiotherapy in Patients With Unbiopsied Lung Tumors (SABR-DETECT)Saurav Verma, Sympascho Young, Thomas A C Kennedy, et al.
Journal of Robotic Surgery|August 8, 2024
Outcomes of open versus robotic partial nephrectomy: a 20-year single institution experienceHarrison Love, Courtney Yong, James E Slaven, et al.
Pathology Oncology Research : POR|August 15, 2015
Feasibility of Targeting PIK3CA Mutations in Head and Neck Squamous Cell CarcinomaJulie A Theurer, William Stecho, John Yoo, et al.
Oncotarget|June 15, 2018
High-throughput testing in head and neck squamous cell carcinoma identifies agents with preferential activity in human papillomavirus-positive or negative cell linesFarhad Ghasemi, Morgan Black, Ren X Sun, et al.
Oncotarget|October 27, 2017
Repurposing Albendazole: new potential as a chemotherapeutic agent with preferential activity against HPV-negative head and neck squamous cell cancerFarhad Ghasemi, Morgan Black, Frederick Vizeacoumar, et al.
Oral Oncology|December 23, 2019
Spleen tyrosine kinase expression is correlated with human papillomavirus in head and neck cancerMorgan Black, Farhad Ghasemi, Ren X Sun, et al.
The Journal of Molecular Diagnostics : JMD|February 7, 2026
Health care impact of comprehensive genomic profiling of solid tumors in patient management using POWER (Precision Oncology at Western University)Pratibha Bhai, Jacob P Turowec, Lee-Anne Pickard, et al.
Lung Cancer (Amsterdam, Netherlands)|July 29, 2024
Treatment patterns and outcomes in KRAS<sup>G12C</sup>-positive advanced NSCLC patients previously treated with immune checkpoint inhibitors: A Canada-wide real-world, multi-center, retrospective cohort studySamir H Barghout, Luna Jia Zhan, Starvroula Raptis, et al.
Pageof 4